Carnosic acid killed drug-resistant stomach bacteria in lab tests and helped clear infection in mice; human benefits remain unknown. The study tested carnosic acid, a natural compound, against Helicobacter pylori. This stomach bacterium is linked to ulcers and stomach cancer. Researchers tested it in the lab and in infected mice, not people. Their goal was to target the harmful bacteria while sparing other gut bacteria. In lab tests, the bacteria showed no detectable resistance after repeated exposure. Carnosic acid worked better in acidic conditions like those in the stomach. It blocked a tool the bacteria use to survive stomach acid. It also damaged their outer barriers and limited their movement. It prevented and broke apart protective groups of bacteria. In mice, researchers paired carnosic acid with omeprazole, a medicine that lowers stomach acid. The pair cleared infection better than a standard three-drug treatment. Researchers reported very little tissue harm and little change in gut bacteria. The supplied summary gives no exact clearance rates, doses, or animal counts. These results support more testing, not a proven treatment for people. For our Cell Membrane Integrity (Phase Angle) community, one distinction matters. This study damaged bacterial barriers; it did not measure human cell health. It offers no evidence that carnosic acid improves this biomarker. The shared wording does not mean the findings explain your readings. When comparing your own numbers with the community, keep that gap in mind. Your readings and notes can describe personal patterns. They cannot show that this compound clears an infection or improves cell health. What changes have you seen in your readings over time, and what habits were you tracking alongside them?